Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
Primary Objective:
To explore associations between biomarkers of atopic dermatitis (AD) and:
The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.
Inclusion criteria:
Exclusion criteria:
Not applicable.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Albany, Georgia 31707, United States
Chicago, Illinois 60611, United States
Cincinnati, Ohio 45229, United States
Greenville, South Carolina 29607, United States
Ciudad Autonoma de Buenos Aires, Buenos Aires C1181ACH, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires C1056ABJ, Argentina
Ciudad Autonoma Bs As, C1121ABE, Argentina
Curitiba, Paraná 80060-900, Brazil
Curitiba, Paraná 80060-900, Brazil
Porto Alegre, Rio Grande do Sul 90020-090, Brazil
São Paulo, São Paulo 04037-002, Brazil